Virtify Partners with Forte Research Systems to Optimize Regulatory Disclosure Compliance

Virtify Partners with Forte Research Systems to Optimize Regulatory Disclosure
                                  Compliance

Virtify® CTRR Integrates with OnCore® Enterprise Research System

PR Newswire

LEXINGTON, Mass. and MADISON, Wis., Sept. 25, 2013

LEXINGTON, Mass.and MADISON, Wis., Sept. 25, 2013 /PRNewswire/ --Virtify,
Inc., a leading innovator in content and regulatory information solutions for
the life sciences industry, and Forte Research Systems, Inc., a leading
developer of specialized clinical trial management software, announced today
the integration of Forte Research Systems' OnCore®Enterprise Research
systemwith Virtify CTRR® (Clinical Trial Registration & Results). The
integration of the two systems will optimize the submission process of
clinical trials into the National Institute of Health's clinicaltrials.gov,
ensuring compliance with disclosure requirements of the Food and Drug
Administration Amendments Act (FDAAA).

(Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO )

Virtify CTRR streamlines and automates the increasingly stringent mandatory
registration and clinical results disclosure obligations to the National
Institute of Health and other registries. Virtify CTRR eliminates duplicate
data entry and polls Forte's OnCore hourly to ensure updated data between the
two systems. Coupled with the benefits of the Virtify CTRR, OnCore becomes the
most comprehensive solution available for seamless compliance with clinical
trial disclosure requirements.

"Virtify is pleased to partner with Forte, the acknowledged and most respected
leader in clinical research management solutions for academic medical
centers," said Dr. Satish Tadikonda, president and CEO of Virtify, Inc.
"OnCore is a proven system that supports streamlined management of robust
portfolios of clinical trials. The Forte partnership reflects Virtify's
continued commitment to the academic medical center market, which has included
a recent 3.2 version of CTRR and several academic customer wins."

"Forte's partnerships are driven by our customers' needs and interests," said
Brian Wulff, Vice President of Sales, Marketing & Partnerships at Forte.
"Virtify is addressing an emerging regulatory compliance issue that impacts
our customers. Forte is pleased to be able to offer, in conjunction with
Virtify, a market leader in regulatory information management, an integration
that assists with the operational efficiency and compliance of our shared
customers."

The OnCore system is Forte's flagship product and is the result of over a
decade of experience working closely with world-class research organizations.
It is used by more than 50 academic medical centers, research hospitals, and
cancer centers. In today's environment of growing trial complexity and
regulatory oversight, the need for a centralized system has never been
greater. 

Learn more about the Virtify-Forte partnership at AACI Annual 2013,
Washington, DC, Sept. 30-Oct. 2, 2013.

About Forte Research Systems, Inc.

Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research
Systems, Inc. develops and markets clinical and translational research
software for better research compliance, patient safety, operational
efficiency, and financial viability. The company's flagship product, the
OnCore® Enterprise Research solution, has been meeting the needs of academic
medical centers, CTSAs, research hospitals, and cancer centers for over a
dozen years. Now, its proven electronic data capture platform is available as
a stand-alone hosted solution, Overture™ EDC. For Research Sites, Site
Networks, and SMOs, Forte offers Allegro® CTMS. Forte is also host to the
Clinical Research Blog and other resources for individuals interested in
excellence in clinical research operations.

About Virtify

Virtify is the leading innovator in content and regulatory information
management solutions for life sciences. Many of the world's leading
organizations rely on Virtify solutions to reduce time-to-market, risk, and
costs by managing and automating the complex regulatory compliance and content
exchange requirements throughout the product life cycle. Virtify's life
science domain expertise has been leveraged by such companies as
Genzyme/Sanofi, Novartis, Pfizer/Wyeth, Regeneron, academic research centers
and CROs. Virtify's easy-to-use software suite is the industry's only
solution to provide a secure, collaborative, web-based environment for
managing regulated content throughout the entire continuum – from pre-clinical
through product registration to commercialization. Visit us at
http://www.virtify.com



SOURCE Virtify, Inc.

Website: http://www.virtify.com
Contact: Eric Meyers, Virtify, Inc., 617-301-8710, emeyers@virtify.com
 
Press spacebar to pause and continue. Press esc to stop.